Radiotherapy-related dural sarcoma and its management: Case report

Creative Commons License

Gürbüz M., Tolunay P. K., AKKUŞ E., EROĞLU Ü., Heper A., ÇAY ŞENLER F.

Journal of Oncological Science, cilt.6, sa.3, ss.179-182, 2020 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6 Sayı: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.37047/jos.2020-76458
  • Dergi Adı: Journal of Oncological Science
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.179-182
  • Anahtar Kelimeler: Antineoplastic protocols, Dura mater, Radiotherapy, Sarcoma
  • Ankara Üniversitesi Adresli: Evet

Özet

© 2020 by Turkish Society of Medical Oncology.Sarcomas are malignant neoplasms that arise from mesenchymal tissues. Sarcomas of the meninges may originate primarily from mesenchymal cells or may be metastases of extracranial soft tissue sarcomas. Radiotherapy (RT)-related dural sarcomas are extremely rare, and the prognosis of RT-related sarcoma patients is worse than that of primary sarcoma. There is no consensus about the management of these very rare, malignant neoplasms. The authors herein report a patient with dural sarcoma and its management. Although the main treatment is surgery, re-irradiation, conventional chemotherapeutics, and targeted therapies are other options. Long term side effects of treatments should always be kept in mind and treatment decisions should be made accordingly.